|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2002-5-10
|
|
pubmed:abstractText |
Combination antiretroviral therapy in a subset of HIV-infected patients, here called CD4-low responders (CD4-LR), fails to produce a rapid rise in CD4 cell counts despite effective control of plasma viral load (< 50 copies/ml). The mechanism responsible for this failure was investigated.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0269-9370
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
24
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1093-101
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12004267-Adult,
pubmed-meshheading:12004267-Anti-HIV Agents,
pubmed-meshheading:12004267-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:12004267-Apoptosis,
pubmed-meshheading:12004267-CD4 Lymphocyte Count,
pubmed-meshheading:12004267-Cohort Studies,
pubmed-meshheading:12004267-Female,
pubmed-meshheading:12004267-HIV Infections,
pubmed-meshheading:12004267-Humans,
pubmed-meshheading:12004267-Interleukin-2,
pubmed-meshheading:12004267-Lymphocyte Subsets,
pubmed-meshheading:12004267-Male,
pubmed-meshheading:12004267-Middle Aged,
pubmed-meshheading:12004267-Prognosis,
pubmed-meshheading:12004267-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:12004267-Receptors, Interleukin-2
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Involvement of Bcl-2 and IL-2R in HIV-positive patients whose CD4 cell counts fail to increase rapidly with highly active antiretroviral therapy.
|
|
pubmed:affiliation |
Unité d'Immunogénétique Cellulaire, Département d'Immunologie and Centre de Recherche Clinique, Institut Pasteur, Paris, France.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
